Dr. Clara Agutu, MBChB
Supervisors
Prof. Eduard Sanders
Prof. Eduard Sanders
Email : ESanders@kemri-wellcome.org Eduard Sanders is an Associate Professor of Tropical Medicine and Global Health at the University of Oxford, and is based in Kilifi, Kenya. He is the principal investigator of several observational studies involving mostly men who have sex with men (MSM) and female sex workers (FSW) in Kilifi, and co-recipient of the SANTHE grant. His interest in diagnosing acute HIV infections was inspired by the many MSM who sought health care prior to seroconversion in coastal Kenya, and the opportunity this presents for reducing onward HIV-1 transmission. He currently leads ongoing studies on the utility of clinical algorithms to identify and diagnose young adults with acute HIV infection at various health facilities in Kenya, enabling early treatment, counselling interventions, and assisted partner notification.
Dr. Susan Graham
Susan Graham is an Associate Professor of Medicine and Global Health, and an Adjunct Associate Professor of Epidemiology at the University of Washington in Seattle and a Visiting Scientist at the KEMRI-Wellcome Trust Programme in Kilifi, Kenya. Her major research interests are in two areas: HIV treatment and prevention, with a focus on marginalised populations; and HIV pathogenesis and disease progression. Her work on HIV treatment and prevention in Kenya has focused on female sex workers at the Ganjoni Clinic in Mombasa and on men who have sex with men (MSM) at the KEMRI clinics on the coast and at the Anza Mapema programme in Kisumu. Her work has also focused on genital HIV-1 shedding and its impact on HIV transmission and on the identification of novel biomarkers of increased cardiovascular risk in HIV-infected patients.
Clara Agutu is a medical doctor with a Masters in public health. She has a keen interest in infectious diseases particularly HIV, TB, Malaria and sexually transmitted infections (STIs) and has worked as a research medical officer at KEMRI. She worked as the lead clinician and study co-ordinator for a multi-centre HIV clinical trial, REALITY (Reduction of Early Mortality in HIV-infected Adults and Children starting Anti-retroviral Therapy), looking to investigate interventions aimed at reducing early mortality during the first three months of starting anti-retroviral therapy, when mortality is the highest in the severely immune-suppressed. She is currently a WHO/TDR clinical research and development fellow at GlaxoSmithKline Biologicals, Belgium working on the malaria vaccine, RTS, S, particularly on phase 2 and 3 trials aimed at improving the vaccines efficacy and subsequent implementation in sub-Saharan Africa. Her SANTHE PhD studentship is in the field of acute HIV screening, for early HIV infection detection and reduction of HIV transmission as she continues the global fight towards the elimination of HIV.
- 51
- 66
- 48
- 104
- 44
- 423